Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Net Cash Flow (2016 - 2026)

Ekso Bionics Holdings has reported Net Cash Flow over the past 14 years, most recently at -$1.5 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 13.12% to -$1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.4 million, a 153.55% decrease, with the full-year FY2025 number at -$5.4 million, down 153.55% from a year prior.
  • Net Cash Flow reached -$1.5 million in Q4 2025 per EKSO's latest filing, up from -$2.5 million in the prior quarter.
  • The five-year high for Net Cash Flow was $36.7 million in Q1 2021, with the low at -$8.7 million in Q4 2022.
  • The 5-year median for Net Cash Flow is -$2.8 million (2022), against an average of -$582150.0.
  • The largest YoY upside for Net Cash Flow was 1688.58% in 2021 against a maximum downside of 294.27% in 2021.
  • Tracing EKSO's Net Cash Flow over 5 years: stood at -$3.1 million in 2021, then tumbled by 182.3% to -$8.7 million in 2022, then skyrocketed by 85.26% to -$1.3 million in 2023, then crashed by 38.23% to -$1.8 million in 2024, then grew by 13.12% to -$1.5 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$1.5 million, -$2.5 million, and -$2.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.